Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

489 public trials 92 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Completed

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors

NCT02644460

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +40 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta, Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Completed

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

NCT02304458

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 25 locations
View Trial Details
Completed

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

NCT02095132

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +37 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

European Low and Intermediate Risk Neuroblastoma Protocol

NCT01728155

Conditions
LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Monash Children's Hospital Clayton, Australia
  • Perth Children's Hospital Nedlands, Australia
  • Sydney Children's Hospital Sydney, Australia
  • PHO Med Uni Graz Graz, Austria
View all 98 locations
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

NCT03236857

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Disease Attributes, +28 more
Locations
  • Univ California, San Francisco /ID# 163460 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 161551 Aurora, Colorado, United States
  • Children's Healthcare of Atlan /ID# 161552 Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute /ID# 163440 Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Completed

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

NCT00033293

Conditions
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neoplasms, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 104 locations
View Trial Details
Completed

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

NCT00084422

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Lucille Salter Packer Children's Hospital, Stanford University Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States
View Trial Details

Related conditions